Hypercalcemia of Malignancy: Management

Hypercalcemia of Malignancy: overview

This algorithm manages hypercalcemia of malignancy by severity and mechanism. The workup confirms the elevation (ionized or albumin-corrected calcium) and checks PTH and PTHrP; the usual mechanisms are PTHrP secretion, osteolytic bone metastases, and calcitriol production in lymphoma.

Mild, asymptomatic hypercalcemia (under 12 mg/dL) is managed with hydration, stopping calcium, vitamin D and thiazides, and treating the cancer. Calcium of 12 mg/dL or higher, or any symptoms, calls for three steps together: intravenous normal saline to restore volume, calcitonin 4 IU/kg every 12 hours for a rapid but short-lived effect (tachyphylaxis after about 48 hours), and zoledronic acid 4 mg intravenously as the definitive treatment, which takes two to four days to work. Denosumab 120 mg subcutaneously is used for bisphosphonate-refractory disease or poor renal function, watching for hypocalcemia. Calcitriol-mediated hypercalcemia in lymphoma or granulomatous disease responds to glucocorticoids. Severe hypercalcemia with renal failure, or when saline cannot be given, may need hemodialysis with a low-calcium bath. Loop diuretics are used only after volume repletion. No specific trials are linked to this chart.

Background reading: Supportive care board review notes.

Hypercalcemia of Malignancy: the algorithm in words

Severity-based treatment and mechanism-specific options. Starting point: High corrected Ca in a cancer patient check iCa, PTH, PTHrP. Full background: Supportive care notes.

Mild, asymptomatic (first-line): Ca under 12 mg/dL: Hydrate; stop Ca, vitamin D, thiazides (treat the cancer).
Ca 12+ or symptoms (first-line): Immediate: IV normal saline (urine output 100-150 mL/h); Works in hours: Calcitonin 4 IU/kg every 12 h (tachyphylaxis after about 48 h); Definitive: Zoledronic acid 4 mg IV (onset 2-4 days; check renal function).
Refractory or poor renal (first-line): Alternative: Denosumab 120 mg SC (no renal adjustment; risk of hypocalcemia).
Calcitriol-mediated (first-line): Lymphoma, granulomatous: Glucocorticoids (prednisone 40-60 mg daily).
Severe + renal failure (first-line): Salvage: Hemodialysis (low-calcium bath) (when saline cannot be given).

Simplified board-prep scaffold; verify against current guidelines (Endocrine Society 2023). Mechanisms: PTHrP (humoral, most common), osteolytic metastases, calcitriol (lymphoma), ectopic PTH (rare). Loop diuretics only after volume repletion, not routinely. Bisphosphonates take 2 to 4 days to work, so pair them with saline and calcitonin when calcium is high or symptomatic. Treat the underlying cancer.